Oxcarbazepine XR — Competitive Intelligence Brief

Oxcarbazepine XR (Oxcarbazepine XR) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticonvulsant; voltage-gated sodium channel blocker. Area: Neurology.

phase 3 Anticonvulsant; voltage-gated sodium channel blocker Voltage-gated sodium channels Neurology Small molecule

Target snapshot

Oxcarbazepine XR (Oxcarbazepine XR) — Supernus Pharmaceuticals, Inc.. Oxcarbazepine XR is an extended-release anticonvulsant that blocks voltage-gated sodium channels to reduce neuronal excitability and prevent seizures.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Oxcarbazepine XR TARGET	Oxcarbazepine XR	Supernus Pharmaceuticals, Inc.	phase 3	Anticonvulsant; voltage-gated sodium channel blocker	Voltage-gated sodium channels
Carbamazepine-Implant	Carbamazepine-Implant	University of Sao Paulo	marketed	Anticonvulsant / Antiepileptic agent	Voltage-gated sodium channels
isobaric mepivacaine	isobaric mepivacaine	Thomas Jefferson University	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
Isobaric 2-chloroprocaine	Isobaric 2-chloroprocaine	Centre Hospitalier Universitaire Saint Pierre	marketed	Local anesthetic (ester)	Voltage-gated sodium channels
Intra-articular Lidocaine	Intra-articular Lidocaine	University of Central Florida	marketed	Local anesthetic	Voltage-gated sodium channels
Generic lamotrigine	Generic lamotrigine	University of Maryland, Baltimore	marketed	Anticonvulsant / Mood stabilizer	Voltage-gated sodium channels; glutamate release inhibition
Lacosamide - rapid titration 2	Lacosamide - rapid titration 2	Seoul National University Hospital	marketed	Anticonvulsant; sodium channel modulator	Voltage-gated sodium channels; CRMP-2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticonvulsant; voltage-gated sodium channel blocker class)

1. Supernus Pharmaceuticals, Inc. · 1 drug in this class